VEGFA and urinary bladder carcinoma: In bladder carcinoma, circRNA-MYLK directly binds to miR-29a and acts as a ceRNA, which contributes to epithelial–mesenchymal transition and bladder carcinoma development through activating VEGFA/VEGFR2 and its downstream Ras/ERK signaling pathway [32].